Developer docs
API playgroundTry for free, no card

Search company profiles

Advanced Brain Monitoring

Full company profile

uuid0000q45

Namestring
Advanced Brain Monitoring
Legal namestring
Advanced Brain Monitoring, Inc.
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Advanced Brain Monitoring (ABM) is a Carlsbad, California-based neuro-diagnostics device company founded around 2000, with a 25-year track record in EEG-based brain monitoring, sleep assessment, and cognitive state evaluation. The company serves clinicians, sleep medicine practitioners, researchers, pharmaceutical sponsors, and government agencies through three product categories: Diagnostics (Sleep Profiler, Sleep Profiler PSG2, PoSAS), Therapy (Night Shift positional sleep apnea therapy, Apnea Guard oral appliance), and Neurotechnology (B-Alert Mobile EEG, STAT Mobile EEG, Insight). Its technology core is a wireless, frontopolar EEG platform with proprietary automated sleep-staging algorithms, AI/ML classifiers for cognitive and psychiatric assessment, and integration with physiological and multimodal signals.

ABM generates revenue through hardware sales (EEG systems and sleep diagnostic devices with recurring disposable sensors and software licenses) and professional services, including Clinical Trials Services and Research Services supporting pharmaceutical, medical device, and academic studies. The company has conducted over 50 clinical trials for major pharmaceutical sponsors and has received more than $40 million in non-dilutive research funding from NIH and DARPA. Distribution is primarily direct-to-enterprise with a global network spanning the US, Europe (including a Belgrade, Serbia regional office), Australia, Asia, and Canada, supported by FDA, ISO 13485, MDSAP, EU MDR, and CE certifications. A new FDA-cleared BEAM cognitive diagnostic platform targets early detection of dementia and psychiatric disorders, with the company actively raising $15 million to scale commercialization.

Short descriptiontext

Advanced Brain Monitoring is a Carlsbad, California neuro-diagnostics device company that develops wireless EEG systems, sleep diagnostic and therapy products, and AI-enabled cognitive assessment platforms for clinicians, sleep medicine practitioners, pharmaceutical sponsors, and academic researchers across global markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCarlsbad, United States
HQ citystring
Carlsbad
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
EEG neurotechnology, sleep diagnostic devices, brain monitoring systems, neurodiagnostic medical devices, wireless EEG systems
Industry4 codes
1Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
CodeHLAHACAEPrimaryYes
2Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers)
CodeHLAHACALPrimaryNo
3Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy)
CodeHLAHAGABPrimaryNo
4Sleep Tech Wearables
CodeCRACAIAGPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Neurodiagnostic Medical Devices
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of neurotechnology products including EEG systems (B-Alert, STAT Mobile), sleep diagnostic devices (Sleep Profiler, PSG2), and therapy devices (Night Shift, Apnea Guard)

advancedbrainmonitoring.com
2Clinical Trial Services
TypeProfessional Services
Description

EEG solutions for pharmaceutical, therapeutic device, and other research trials. The company has conducted over 50 clinical trials for major pharmaceutical sponsors

advancedbrainmonitoring.com
3Research Services
TypeProfessional Services
Description

EEG research services including protocol design & development, system integration, data analyses and grant proposals

advancedbrainmonitoring.com
4Software Licensing
TypeSubscription Recurring
Description

Sleep Profiler software license included with purchase of disposable sensors. X-Series EEG systems include software licenses

advancedbrainmonitoring.com
5Research Funding
TypeLicensing Royalties
Description

Over $40 million in non-dilutive research funding primarily from NIH and DARPA

nia.nih.gov
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Pricing details3 tiers
1Sleep Profiler - Device warranty 24 months, expected service life 60 months or 600 nights
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Sleep Profiler device warranty: 24 months (12 months for battery and SD Card). PSG2 airflow adapter: 12 months. Sensor strip: 50 nights. Headband: 25 nights. Cables: 12 months.

advancedbrainmonitoring.com
2Night Shift - Device warranty 24 months, expected service life 36 months
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Night Shift device: 24 months warranty (12 months for battery and haptic motors). Neck strap/chest belt: 6 months warranty. Expected service life: 36 months for device, 24 months for battery.

advancedbrainmonitoring.com
3X-Series (Stat/B-Alert) - Device warranty 24 months, expected service life 60 months
ModelUnit PricingBilling cadencePay-as-you-go
Notes

X10/X24 device: 24 months warranty (12 months for battery and SD Card). Reusable Sensor Strip: 25 uses. Reusable Adapter Board: 50 uses. Headband: 25 uses.

advancedbrainmonitoring.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Advanced Brain Monitoring develops and manufactures FDA-cleared, wireless EEG-based medical devices and neurotechnology platforms for sleep diagnostics (Sleep Profiler, Sleep Profiler PSG2, PoSAS), positional sleep apnea therapy (Night Shift, Apnea Guard), and clinical/research neurotechnology (B-Alert Mobile EEG, STAT Mobile EEG, Insight, BEAM). The company sells these devices plus bundled proprietary software licenses, automated sleep-staging AI algorithms, and EEG-based clinical trial and research services directly to clinicians, hospitals, pharmaceutical sponsors, and academic researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 50 clinical trials conducted for major pharmaceutical sponsors
+2 more records
Product overview1 text field

Advanced Brain Monitoring is a neuro-diagnostics device company offering a portfolio of three product categories: Diagnostics (Sleep Profiler, Sleep Profiler PSG2, and PoSAS), Therapy (Night Shift and Apnea Guard), and Neurotechnology (B-Alert Mobile EEG, STAT Mobile EEG, and Insight). The Diagnostics products use frontopolar EEG-based automated sleep staging to assess sleep architecture and continuity. The Therapy line provides non-invasive positional sleep apnea interventions. The Neurotechnology line comprises wireless EEG systems for medical and non-medical applications including brain-computer interface development, team neurodynamics, and fatigue management. The company also provides Clinical Trials and Research services, supporting pharmaceutical and academic research with EEG solutions. The EEG technology core is shared across diagnostics and neurotechnology, with automated scoring algorithms processing frontopolar EEG signals. A new BEAM™ platform (FDA-cleared) integrates AI/ML for early detection of dementia and psychiatric disorders. The company has 25 years of experience, over $40 million in non-dilutive research funding from NIH and DARPA, and has conducted over 50 clinical trials.

Product and service1 record
1Sleep Profiler
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Company has conducted over 50 clinical trials for pharmaceutical sponsors using EEG solutions. This represents core business revenue stream and validation of technology through pharmaceutical partnerships.

Strategic tierSupportTypeImplementation/ SI/ Consulting Partner
Description

Data protection representative appointed for GDPR compliance in EU/EEA, UK, and Switzerland. Located in multiple European countries to handle data privacy inquiries and regulatory compliance.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Natus Medical is a leading provider of neurodiagnostic and EEG equipment for hospitals and clinics. It directly competes with ABM in EEG systems, sleep diagnostics, and neurology-focused medical devices.

TypeDirect peer
Description

Compumedics manufactures EEG, sleep diagnostics, and clinical research systems used worldwide. It competes directly with ABM in EEG hardware, polysomnography, and clinical trial services.

TypeDirect peer
Description

Cadwell designs and manufactures neurodiagnostic equipment including EEG, EMG, and sleep monitoring systems. Directly comparable to ABM's STAT Mobile EEG and B-Alert product lines serving clinical neurology and sleep medicine markets.

TypeDirect peer
Description

Itamar Medical (acquired by ZOLL) provides home sleep testing and wearable diagnostic devices for sleep apnea. Competes with ABM's Sleep Profiler and PSG2 in-home sleep diagnostics, particularly for cardiology and primary care channels.

TypeBroad incumbent
Description

ResMed is a global leader in sleep apnea therapy and diagnostics with extensive distribution and reimbursement infrastructure. Overlaps with ABM in sleep diagnostics and positional therapy through Night Shift and Apnea Guard products.

TypeBroad incumbent
Description

Philips offers comprehensive sleep and respiratory solutions including home sleep testing and CPAP therapy. A broad incumbent competing with ABM across multiple sleep diagnostics and therapy product categories.

TypeEmerging player
Description

Wave Neuroscience provides EEG-based diagnostics and personalized neurostimulation for brain conditions including TBI and PTSD. Competes with ABM in the emerging EEG-based cognitive and neurological diagnostic space, particularly for BEAM-adjacent applications.

TypeEmerging player
Description

EMOTIV develops consumer and research-grade wireless EEG headsets for cognitive state monitoring, BCI, and neuromarketing applications. Comparable to ABM's B-Alert product line for non-medical and operational neuroscience applications.

TypeEmerging player
Description

Neurable builds EEG-based brain-computer interface technology for consumer and enterprise applications including productivity monitoring. Represents an emerging player in the same non-medical EEG/Brain-Computer Interface space as ABM's B-Alert platform.

TypeEmerging player
Description

Cumulus Neuroscience develops EEG-based digital biomarkers for clinical trials in neurodegenerative and psychiatric disorders. Directly comparable to ABM's clinical trial services and BEAM cognitive diagnostic platform targeting pharma-sponsored CNS trials.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Advanced Brain Monitoring

Neurodiagnostic Medical Devicesadvancedbrainmonitoring.com

Advanced Brain Monitoring is a Carlsbad, California neuro-diagnostics device company that develops wireless EEG systems, sleep diagnostic and therapy products, and AI-enabled cognitive assessment platforms for clinicians, sleep medicine practitioners, pharmaceutical sponsors, and academic researchers across global markets.

What Advanced Brain Monitoring does

Advanced Brain Monitoring (ABM) is a Carlsbad, California-based neuro-diagnostics device company founded around 2000, with a 25-year track record in EEG-based brain monitoring, sleep assessment, and cognitive state evaluation. The company serves clinicians, sleep medicine practitioners, researchers, pharmaceutical sponsors, and government agencies through three product categories: Diagnostics (Sleep Profiler, Sleep Profiler PSG2, PoSAS), Therapy (Night Shift positional sleep apnea therapy, Apnea Guard oral appliance), and Neurotechnology (B-Alert Mobile EEG, STAT Mobile EEG, Insight). Its technology core is a wireless, frontopolar EEG platform with proprietary automated sleep-staging algorithms, AI/ML classifiers for cognitive and psychiatric assessment, and integration with physiological and multimodal signals.

ABM generates revenue through hardware sales (EEG systems and sleep diagnostic devices with recurring disposable sensors and software licenses) and professional services, including Clinical Trials Services and Research Services supporting pharmaceutical, medical device, and academic studies. The company has conducted over 50 clinical trials for major pharmaceutical sponsors and has received more than $40 million in non-dilutive research funding from NIH and DARPA. Distribution is primarily direct-to-enterprise with a global network spanning the US, Europe (including a Belgrade, Serbia regional office), Australia, Asia, and Canada, supported by FDA, ISO 13485, MDSAP, EU MDR, and CE certifications. A new FDA-cleared BEAM cognitive diagnostic platform targets early detection of dementia and psychiatric disorders, with the company actively raising $15 million to scale commercialization.

Advanced Brain Monitoring firmographics

Firmographics
Name
Advanced Brain Monitoring
Legal name
Advanced Brain Monitoring, Inc.
Website
https://advancedbrainmonitoring.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
51–100 employees
Short description
Advanced Brain Monitoring is a Carlsbad, California neuro-diagnostics device company that develops wireless EEG systems, sleep diagnostic and therapy products, and AI-enabled cognitive assessment platforms for clinicians, sleep medicine practitioners, pharmaceutical sponsors, and academic researchers across global markets.
Ownership category
akta.pro rank

Advanced Brain Monitoring industry classification

Industry
Product category
Neurodiagnostic Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
akta.pro secondary industries
Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB), Sleep Tech Wearables (CRACAIAG)

Keywords

  • EEG neurotechnology
  • Sleep diagnostic devices
  • Brain monitoring systems
  • Neurodiagnostic medical devices
  • Wireless EEG systems

Where Advanced Brain Monitoring is headquartered

Location

Headquarters

HQ city
Carlsbad
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Advanced Brain Monitoring business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Medical Device Sales: Sale of neurotechnology products including EEG systems (B-Alert, STAT Mobile), sleep diagnostic devices (Sleep Profiler, PSG2), and therapy devices (Night Shift, Apnea Guard)
  2. Clinical Trial Services: EEG solutions for pharmaceutical, therapeutic device, and other research trials. The company has conducted over 50 clinical trials for major pharmaceutical sponsors
  3. Research Services: EEG research services including protocol design & development, system integration, data analyses and grant proposals
  4. Software Licensing: Sleep Profiler software license included with purchase of disposable sensors. X-Series EEG systems include software licenses
  5. Research Funding: Over $40 million in non-dilutive research funding primarily from NIH and DARPA

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goSleep Profiler - Device warranty 24 months, expected service life 60 months or 600 nights
Unit PricingPay-as-you-goNight Shift - Device warranty 24 months, expected service life 36 months
Unit PricingPay-as-you-goX-Series (Stat/B-Alert) - Device warranty 24 months, expected service life 60 months

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Advanced Brain Monitoring product offering

Product offering

Core offering

Advanced Brain Monitoring develops and manufactures FDA-cleared, wireless EEG-based medical devices and neurotechnology platforms for sleep diagnostics (Sleep Profiler, Sleep Profiler PSG2, PoSAS), positional sleep apnea therapy (Night Shift, Apnea Guard), and clinical/research neurotechnology (B-Alert Mobile EEG, STAT Mobile EEG, Insight, BEAM). The company sells these devices plus bundled proprietary software licenses, automated sleep-staging AI algorithms, and EEG-based clinical trial and research services directly to clinicians, hospitals, pharmaceutical sponsors, and academic researchers.

Product overview

Advanced Brain Monitoring is a neuro-diagnostics device company offering a portfolio of three product categories: Diagnostics (Sleep Profiler, Sleep Profiler PSG2, and PoSAS), Therapy (Night Shift and Apnea Guard), and Neurotechnology (B-Alert Mobile EEG, STAT Mobile EEG, and Insight). The Diagnostics products use frontopolar EEG-based automated sleep staging to assess sleep architecture and continuity. The Therapy line provides non-invasive positional sleep apnea interventions. The Neurotechnology line comprises wireless EEG systems for medical and non-medical applications including brain-computer interface development, team neurodynamics, and fatigue management. The company also provides Clinical Trials and Research services, supporting pharmaceutical and academic research with EEG solutions. The EEG technology core is shared across diagnostics and neurotechnology, with automated scoring algorithms processing frontopolar EEG signals. A new BEAM™ platform (FDA-cleared) integrates AI/ML for early detection of dementia and psychiatric disorders. The company has 25 years of experience, over $40 million in non-dilutive research funding from NIH and DARPA, and has conducted over 50 clinical trials.

Differentiator

Problem solved

Functional benefit

Products and services

  • Sleep Profiler

Quantifiable outcome

  • Over 50 clinical trials conducted for major pharmaceutical sponsors
  • +2 more outcomes

Companies that use Advanced Brain Monitoring

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles6 records

Advanced Brain Monitoring technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature7 records

Advanced Brain Monitoring partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and support.

  • Major Pharmaceutical SponsorscoreStrategic or Co-development PartnerCompany has conducted over 50 clinical trials for pharmaceutical sponsors using EEG solutions. This represents core business revenue stream and validation of technology through pharmaceutical partnerships.
  • DataRepsupportImplementation/ SI/ Consulting PartnerData protection representative appointed for GDPR compliance in EU/EEA, UK, and Switzerland. Located in multiple European countries to handle data privacy inquiries and regulatory compliance.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Advanced Brain Monitoring competitors and assessment

Company assessment

Direct peers

  • Natus Medical: Natus Medical is a leading provider of neurodiagnostic and EEG equipment for hospitals and clinics. It directly competes with ABM in EEG systems, sleep diagnostics, and neurology-focused medical devices.
  • Compumedics: Compumedics manufactures EEG, sleep diagnostics, and clinical research systems used worldwide. It competes directly with ABM in EEG hardware, polysomnography, and clinical trial services.
  • Cadwell Industries: Cadwell designs and manufactures neurodiagnostic equipment including EEG, EMG, and sleep monitoring systems. Directly comparable to ABM's STAT Mobile EEG and B-Alert product lines serving clinical neurology and sleep medicine markets.
  • Itamar Medical: Itamar Medical (acquired by ZOLL) provides home sleep testing and wearable diagnostic devices for sleep apnea. Competes with ABM's Sleep Profiler and PSG2 in-home sleep diagnostics, particularly for cardiology and primary care channels.

Broad incumbents

  • ResMed: ResMed is a global leader in sleep apnea therapy and diagnostics with extensive distribution and reimbursement infrastructure. Overlaps with ABM in sleep diagnostics and positional therapy through Night Shift and Apnea Guard products.
  • Philips Respironics: Philips offers comprehensive sleep and respiratory solutions including home sleep testing and CPAP therapy. A broad incumbent competing with ABM across multiple sleep diagnostics and therapy product categories.

Emerging players

  • Wave Neuroscience: Wave Neuroscience provides EEG-based diagnostics and personalized neurostimulation for brain conditions including TBI and PTSD. Competes with ABM in the emerging EEG-based cognitive and neurological diagnostic space, particularly for BEAM-adjacent applications.
  • EMOTIV: EMOTIV develops consumer and research-grade wireless EEG headsets for cognitive state monitoring, BCI, and neuromarketing applications. Comparable to ABM's B-Alert product line for non-medical and operational neuroscience applications.
  • Neurable: Neurable builds EEG-based brain-computer interface technology for consumer and enterprise applications including productivity monitoring. Represents an emerging player in the same non-medical EEG/Brain-Computer Interface space as ABM's B-Alert platform.
  • Cumulus Neuroscience: Cumulus Neuroscience develops EEG-based digital biomarkers for clinical trials in neurodegenerative and psychiatric disorders. Directly comparable to ABM's clinical trial services and BEAM cognitive diagnostic platform targeting pharma-sponsored CNS trials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Advanced Brain Monitoring social profiles

Digital presence

Advanced Brain Monitoring compliance and trust

Trust signal

Compliance7 records

Advanced Brain Monitoring financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Advanced Brain Monitoring leadership team

Management profile

Number of profiles

Profiles2 records

Advanced Brain Monitoring funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Advanced Brain Monitoring M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Brain Monitoring

What does Advanced Brain Monitoring do?

Advanced Brain Monitoring develops and manufactures FDA-cleared, wireless EEG-based medical devices and neurotechnology platforms for sleep diagnostics (Sleep Profiler, Sleep Profiler PSG2, PoSAS), positional sleep apnea therapy (Night Shift, Apnea Guard), and clinical/research neurotechnology (B-Alert Mobile EEG, STAT Mobile EEG, Insight, BEAM). The company sells these devices plus bundled proprietary software licenses, automated sleep-staging AI algorithms, and EEG-based clinical trial and research services directly to clinicians, hospitals, pharmaceutical sponsors, and academic researchers.

Is Advanced Brain Monitoring a public or private company?

Advanced Brain Monitoring is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Advanced Brain Monitoring founded?

Advanced Brain Monitoring was founded in 2000. It employs 51 to 100 people.

Where is Advanced Brain Monitoring based?

Advanced Brain Monitoring is headquartered in Carlsbad, United States, in the North America region.

How does Advanced Brain Monitoring make money?

Five revenue lines are on record. Medical Device Sales are the primary driver. The others are clinical Trial Services, research Services, software Licensing and research Funding.

Who are Advanced Brain Monitoring's main competitors?

Direct peers on record are Natus Medical, Compumedics, Cadwell Industries and Itamar Medical. Broad incumbents are ResMed and Philips Respironics. Emerging players are Wave Neuroscience, EMOTIV, Neurable and Cumulus Neuroscience.

Does Advanced Brain Monitoring have an API?

No public API is recorded for Advanced Brain Monitoring.

What industry is Advanced Brain Monitoring in?

Advanced Brain Monitoring's product category is Neurodiagnostic Medical Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLAHACAL, Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comBrain-Computer Interface Market to grow at 14.80% CAGR | Leading Companies 2026 - Nihon Kohden Corporation, Advanced Brain Monitoring Inc, ANT NeuroThe article reports that the Brain-Computer Interface (BCI) market is projected to grow at a CAGR of 14.80% during 2023-2030, highlighting recent developments by companies such as Neuralink, Precision Neuroscience, and others in the US and Japan. Major companies like Nihon Kohden, Advanced Brain Monitoring Inc, and ANT Neuro are actively advancing neurotechnology and BCI applications across various regions.openPR.comBrain Computer Interface Market Booming with Rapid Growth Through 2033 | Advanced Brain Monitoring, Inc., Emotiv Systems Inc.Coherent Market Insights has released a market research report on the Brain Computer Interface industry, covering the forecast period from 2026 to 2033. The analysis highlights key players such as Advanced Brain Monitoring, Inc. and Emotiv Systems Inc., while examining market segments including product types, applications, and end users across global regions.openPR.comBrain-Computer Interface (BCI) Market Opportunities & Growth Trends: Ahlstrom and Key Competitors Advanced Brain Monitoring, Inc., Cadwell Industries, Inc., Cortech SolutionsThe global brain-computer interface market was valued at $4.02 billion in 2024 and is projected to reach $10.86 billion by 2032, a CAGR of 14.61%. Growth is driven by neurotechnology, AI integration, and demand for non-invasive neural interfaces across healthcare, defense, gaming, and assistive technologies.LinkedInNorth America Non-Invasive BCI Market: By ApplicationInnovative Market Trends Hub published a market research report projecting the North America non-invasive brain-computer interface (BCI) market to grow from USD 2.45 billion in 2024 to USD 12.12 billion by 2033 at a CAGR of 19.8%. The report identifies key growth drivers including increased adoption in healthcare, gaming, and research, alongside technological advancements in EEG and AI integration. It also highlights major industry players such as Advanced Brain Monitoring, Emotiv, and Natus Medical Incorporated.openPR.comBrain Computer Interface Market Booming Worldwide from 2025 to 2032 | Advanced Brain Monitoring, Inc. and Emotiv Systems Inc. Leads InnovationThe global brain computer interface market is projected to grow from USD 1.25 billion in 2025 to USD 1.5 billion by 2032, a CAGR of 14.4%. Growth is driven by non-invasive device demand, AI integration, and healthcare applications, with Asia-Pacific leading exports.National Center for Biotechnology InformationNIA Small Business Showcase: Advanced Brain MonitoringAdvanced Brain Monitoring, a Carlsbad, California-based neurotechnology company, is showcasing its BEAM™ platform, an FDA-cleared EEG-based cognitive diagnostic system designed for early detection of dementia and psychiatric disorders using AI and machine learning algorithms. The global cognitive diagnostic market is estimated at $102 billion with an 8% CAGR, and the company is currently seeking $15 million in funding over 15 months to commercialize BEAM, scale manufacturing, and expand into psychiatry and general medicine markets. The company has 25 years of experience, has received over $40 million in non-dilutive research funding primarily from NIH and DARPA, and has conducted over 50 clinical trials for major pharmaceutical sponsors.PR NewswireEEG Devices Market: Organic and Inorganic Growth Strategies of Leading VendorsTechnavio has announced a market research report forecasting the electroencephalography (EEG) devices market to grow by USD 444.18 million between 2021 and 2025. The report identifies Advanced Brain Monitoring Inc., BrainScope Co. Inc., and Cadwell Industries Inc. as major participants in this sector, noting that pandemic-related technological adoption is driving growth. Key drivers include the rising prevalence of neurological disorders and the increasing popularity of hybrid brain-computer interface techniques.PR NewswireThe global brain monitoring market generated $3,850 million in 2017, and is projected to reach $6,595 million by 2025, growing at a CAGR of 6.9% from 2018 to 2025The global brain monitoring market was valued at $3,850 million in 2017 and is projected to reach $6,595 million by 2025, growing at a compound annual growth rate of 6.9% during the forecast period. Market growth is expected to be driven by increasing geriatric population and rising prevalence of neurological disorders, as well as technological advancements, while stringent government regulations and unfavorable reimbursement policies may constrain expansion. Key players identified in the brain monitoring industry include Advanced Brain Monitoring, CAS Medical Systems, Compumedics, GE Healthcare, Philips Healthcare, Medtronic, Natus Medical, Neural Analytics, and Siemens AG.PR NewswireBrain Monitoring: Worldwide Market Analysis & Forecast, 2019 to 2024 - Electroencephalograph to Dominate with a CAGR of 8.25%ResearchAndMarkets.com published a market report on the global brain monitoring industry, estimating the market will grow from USD 1,514.52 million in 2018 to USD 2,430.18 million by 2024 at a CAGR of 8.2%. Key growth drivers include aging demographics, rising incidence of brain disorders, and increasing device portability, with electroencephalograph (EEG) technology expected to hold the largest product segment share. North America, led by the United States, currently dominates the market due to favorable reimbursement policies and technological advancements.PR NewswireGlobal Brain Computer Interface Market Trends, Opportunities and Forecasts 2017-2023: Increasing Demand in the Field of Neuroscience and Information and Communication TechnologyResearchAndMarkets has added a new report forecasting the global brain computer interface (BCI) market to reach US$1.840 billion by 2023, growing at a CAGR of 17.59% from 2017. The growth is driven by increasing demand in neuroscience and ICT, though challenges such as ethical issues and data privacy concerns remain. Key players identified in the competitive landscape include Nihon Kohden Corporation, Advanced Brain Monitoring, Inc, and ANT Neuro.